TPX2 and neoplasm: A bone marrow transfer experiment with TPX2-knockdown or TPX2-overexpressing cells into tumor-bearing CD8−/− mice showed that tumor growth was significantly delayed by TPX2-overexpressing CD8+ T cells but enhanced by TPX2-knockdown CD8+ T cells.